Durvalumab Plus FLOT Ups Survival in Early Upper-GI Cancer

Overall survival outcomes in MATTERHORN trial support perioperative durvalumab plus chemotherapy as standard of care.
Medscape Medical News

source https://www.medscape.com/viewarticle/durvalumab-plus-flot-ups-survival-early-upper-gi-cancer-2025a1000sar?src=rss